sentences:  The FDA was more likely to approve claims for symptom reduction, while the EMA approved relatively more claims for improvement in functioning or HrQoL.Operationalizing success in multi-modal pain therapy is a challenge and is up to now characterized by tremendous heterogeneity.There are efforts to define core sets of patient-relevant outcome variables to be measured in clinical trials in general and for multi-modal pain therapy.